Across TCGA pan-cancer cohorts, MIR297 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR297 data layer compared with 1 for mutation status.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR297 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR297 expression acts as an unfavorable survival marker.

KIRP, STAD, and UCEC are the cancer types where MIR297 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.161	0.904	<.001	81	view →
STAD	OS	Tertile	II,III,IV	0.162	0.566	.016	27	view →
UCEC	DFS	Tertile	All	0.123	0.648	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR297 tumor-vs-normal RNA expression · all MIR297 data types